Developing Drugs For Developing Countries
نویسندگان
چکیده
منابع مشابه
Developing drugs for developing countries.
Infectious and parasitic diseases create enormous health burdens, but because most of the people suffering from these diseases are poor, little is invested in developing treatments. We propose that developers of treatments for neglected diseases receive a "priority review voucher." The voucher could save an average of one year of U.S. Food and Drug Administration (FDA) review and be sold by the...
متن کاملAffordable drugs for developing countries.
In November 2002, the Common Market for Eastern and Southern Africa (COMESA), Africa’s major free trade bloc, applied to the World Trade Organization (WTO) for the right to manufacture low-cost drugs to treat AIDS. The Secretary General of the Organization Erastus Mwencha, in announcing this move, said that drugs must be cheaper as the world could not continue to see people dying for the sake o...
متن کاملDeveloping leaders? Developing countries?
A visit to Ghana, with the hosts interested in developing leaders and the guest interested in developing countries, led to a questioning of both. Three approaches to development are discussed. The top-down government planning approach, discredited with the fall of communism, has been replaced by an outside-in ‘globalisation’ approach, which is now promoted as the way to develop an economy. But ...
متن کاملCompanies reduce prices for HIV drugs in developing countries.
This article reports the decision of pharmaceutical companies to reduce the prices of anti-HIV drugs in developing countries. It is stated that some of the companies have pledged to sell the pharmaceuticals at prices just above the manufacturing costs, at a discount of up to 90%. This strategy is part of an unprecedented effort to combat AIDS in sub-Saharan Africa. Participating companies in...
متن کاملDeveloping biobanks in developing countries
We call for the development of human biobanks in developing countries and describe several examples from low income countries which are already building their own biobanks. Developing human biobanks in developing countries requires strengthening of the research capacity to use the new technologies, as well as a shift in research investment priorities in order to reduce the inequity in internati...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Health Affairs
سال: 2006
ISSN: 0278-2715,1544-5208
DOI: 10.1377/hlthaff.25.2.313